期刊文献+

慢性心力衰竭患者甲状腺激素的变化及意义 被引量:2

Change and meaning of Thyroid hormone in patients with chronic congestive heart failure
下载PDF
导出
摘要 目的:探讨慢性心力衰竭患者甲状腺激素(T3、T4、FT3、FT4、TSH)水平的变化及意义。方法:用放免法测定60例慢性充血性心力衰竭患者(心衰组)抗心衰治疗前后的血清T3、T4、FT3、FT4、TSH水平,与46例健康体检者(对照组)比较。结果:心衰组T3、FT3较对照组下降(P<0.05或P<0.01),T4、FT4仅在重度心衰时下降(P<0.05),而TSH在两组间无明显差异;抗心衰治疗后,T3、FT3水平明显上升(P<0.05)。结论:T3、FT3可作为反映慢性充血性心力衰竭严重程度、治疗效果和预后的一项判定指标。 Objective: To explore the change and meaning of thyroid hormone(T3、T4、FT3、FT4、TSH) in chronic congestive heart failure. Methods: Serum concentrations of thyroid hormone(T3、T4、FT3、FT4、TSH) before and after treatment were measured by radiommunossay and compared in 60 patients with CHF(hrart failure group) and 46 healthy subjects(control group).Results: The serum concentration of T3、FT3 in patients with CHF were lower than control group(P<0.05 or P<0.01), The serum concentration of T4、FT4 decreased in severe CHF patients(P<0.05),TSH showed no significant differencese between the two groups.After treatments, The serum concentration of T3、FT3 in patients with CHF significantly increased(P<0.05).Conclusion: T3、FT3 could be taken as determinative indicators which reflect severity of CHF ,curative effectiveness and prognosis.
出处 《河南医学研究》 CAS 2005年第2期153-155,共3页 Henan Medical Research
关键词 充血性心力衰竭 甲状腺激素 治疗 预后 T3 T4 FT3 Heart failure Congestive Thyroid hormone
  • 相关文献

参考文献6

  • 1周仁.正常甲状腺病态综合征[J].国外医学(内分泌学分册),1998,18(1):40-42. 被引量:47
  • 2GOMBERG-MAITLAND M,FRISHMAN,W.H.Thyroid hormone and cardiovascular disease[ J]. Am Heart J, 1998,135 (2pt1): 187-196.
  • 3IERVASI G, PINGITORE A, LANDI P. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease [ J ]. Circulation,2003,107(5) :708-713.
  • 4姜腾勇,吴学思.慢性充血性心力衰竭外周甲状腺素水平变化[J].心肺血管病杂志,2001,20(1):27-29. 被引量:19
  • 5张玉顺 李寰(等).甲状腺激素治疗心血管疾病的研究进展[J].心血管病学进展,1998,19(5):28-28.
  • 6OPASICH C, PACINI F, AMBROSLNO N, et al . Sick euthyroid syndrome in patients with moderate-to-severe chronic heart failure [ J]. Eur Heart,1996,17(12): 1860-1866.

二级参考文献9

  • 1Moruzzi P,Doria E,Agotini PG.Medium term effectiveness of L-Thyroxine treatment in idiopathic dialated cardiomyopathy[].The American Journal of Medicine.1996
  • 2Hamilton MA,Stevenson LW,Luu,et al.Altered thyroid hormone metabolism in advanced heart failure[].Journalism Assn of Community College.1990
  • 3Morkin E,Flink IL,Goldman S.Biochemical and physiologic effects of thyroid hormone on cardiac performance[].Progress in Cardiovascular Diseases.1983
  • 4Biondi B,Fazio S,Carlla C,et al.Control of adrenergic overactivity by β-blockade improve quality of life in patients on long-term supressive therapy with levothyroxine[].The Journal of Clinical Endocrinology.1994
  • 5Chopra IJ,Huang TS,Beredo A,et al.Evidence for an inhibitor of extrathyroidal conversion of thyroxine to 3, 5, 3′triiodothyronine in sera of patients with nonthyroidal illness[].Journal of Clinical Endocrinology and Metabolism.1985
  • 6Opasich C,Pacini F,Ambrosino N,et al.Sick euthyroid syndrome in patients with moderate-to-severe chronic heart failure[].European Heart Journal.1996
  • 7Henson LC,Heber D.Whole body protein breakdown rates and hormonal adaptation in fasted obese subjects[].Journal of Clinical Endocrinology and Metabolism.1983
  • 8Willianms LT,Leftkowitz RJ,Watanabe AM,et al.Thyroid hormone regulation of β-receptor number[].Journal of Biological Chemistry.1977
  • 9Moruzzi P,Doria E,Agostini PG,et al.Usefulness of L-thyroxine to improve cardiac and exercise performance in idiopathic dialated cardiomyopathy[].The American Journal of Cardiology.1994

共引文献79

同被引文献3

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部